Cerebral Perfusion Pressure (CPP)

Intracranial pressure (ICP) monitoring and the derived parameter of cerebral perfusion pressure (CPP) are cornerstones of neurocritical care management in traumatic brain injury (TBI), subarachnoid haemorrhage, intracerebral haemorrhage, and other conditions causing cerebral oedema or mass effect. The skull is a fixed rigid container holding three compartments whose volumes must remain constant — this is the Monroe-Kellie doctrine: the sum of brain tissue volume, blood volume, and cerebrospinal fluid (CSF) volume is constant. Any increase in one compartment must be compensated by a decrease in another; when compensation is exhausted, ICP rises. Normal ICP in adults is 5-15 mmHg. Sustained ICP above 20-22 mmHg is the standard treatment threshold in TBI, and values above 40 mmHg represent severely elevated ICP with imminent risk of herniation. Cerebral Perfusion Pressure (CPP) is calculated as the difference between Mean Arterial Pressure (MAP) and ICP: CPP = MAP - ICP. CPP represents the net driving force of blood through the cerebral circulation and is the physiologically meaningful quantity for ensuring adequate oxygen delivery to the brain. The Brain Trauma Foundation (BTF) guidelines recommend maintaining CPP between 60 and 70 mmHg in TBI. Cushing's triad — bradycardia, systemic hypertension, and irregular respiration — is a late clinical sign of severely elevated ICP and impending brainstem herniation that represents a neurological emergency. ICP can be measured invasively via intraventricular catheter (EVD), intraparenchymal fibreoptic bolt, or non-invasively estimated through optic nerve sheath diameter ultrasonography.

PrimeCalcPro provides professional-grade tools trusted by businesses and academics.

1. 1Measure or calculate MAP: Mean Arterial Pressure = (Systolic BP + 2 × Diastolic BP) / 3, expressed in mmHg.
2. 2Obtain ICP from an invasive monitor (EVD or intraparenchymal bolt at the level of the foramen of Monro) or estimate using non-invasive methods (optic nerve sheath diameter >5 mm on ultrasound suggests ICP >20 mmHg).
3. 3Calculate CPP = MAP - ICP; a CPP below 50 mmHg causes cerebral ischaemia; above 70 mmHg risks hyperaemia and secondary oedema.
4. 4Target ICP <20 mmHg using tiered medical management: head-of-bed elevation 30°, osmotherapy (mannitol 0.25-1 g/kg or 3% NaCl), sedation, CSF drainage via EVD, and in refractory cases decompressive craniectomy.
5. 5Maintain CPP 60-70 mmHg using vasopressors if MAP is insufficient relative to ICP, while simultaneously reducing ICP.
6. 6Monitor for Cushing's triad — bradycardia + systemic hypertension + irregular breathing — as a late sign of transtentorial herniation requiring immediate intervention (head of bed flat, mannitol, emergency neurosurgery).
7. 7Interpret ICP waveforms: three components A (plateau waves, >20 mmHg, pathological), B (0.5-2/min, moderate significance), and C waves (6/min, less significant) provide additional information about cerebrovascular reserve.

• !Targeting MAP elevation without simultaneously monitoring ICP — raising MAP in a patient with disrupted autoregulation can increase ICP and worsen CPP despite a higher MAP.
• !Using mannitol in a dehydrated or hypovolaemic patient — mannitol induces osmotic diuresis and can precipitate haemodynamic instability, worsening CPP despite ICP reduction.
• !Prolonged hyperventilation to pCO2 <30 mmHg — while effective for acute ICP reduction, aggressive hyperventilation causes cerebral vasoconstriction and ischaemia if maintained beyond 30-60 minutes.
• !Misidentifying Cushing's triad as a stable finding rather than a neurological emergency — any appearance of this triad should trigger immediate action.
• !Not zeroing the ICP transducer at the level of the foramen of Monro (external auditory meatus) — incorrect reference level produces systematically inaccurate ICP readings.
• !Failing to account for ICP when managing hypertension in a TBI patient — reducing blood pressure to 'normal' levels in a patient with elevated ICP may critically reduce CPP.